• Mashup Score: 0

    Marlise Luskin,MD, MSCE- Medical Oncology- Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program and education director for the adult leukemia program. The presentation focused on the use of the drug venetoclax (and its related drugs) in the treatment of acute lymphoblastic leukemia (ALL), particul…

    Tweet Tweets with this article
    • Dive into the potential of #venetoclax & #BCL2 inhibitors reshaping #ALL treatment! Join Dr. Marlise Luskin as she explores breakthroughs & synergies. Exciting advancements await! [slides][video]https://t.co/yXXpX2m7vi ➡️ Watch now! @_MDEducation @Ryan_fitzpatric #Leukemia https://t.co/AA4f0StMX5

  • Mashup Score: 18

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • w/@jeff_sharman we🗣️SoC for #CLL & key📝 to 🔍 in the community: - Fixed⏰Rx vs. BTKi - #Obinutuzumab/#Rituximab - #Venetoclax management Full discussion: - https://t.co/YuEQBXnZHX - Also on the “Oncology Brothers” podcast #Leusm #HemeTwitter #MedTwitter #OncTwitter https://t.co/n76iML2HOm

  • Mashup Score: 0

    Branko Cuglievan, MD- Assistant Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX – Section Chief, Leukemia/Lymphoma, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer C…

    Tweet Tweets with this article
    • 🔍 Uncover Pediatric #AML treatment insights with Branko Cuglievan, MD: Menin inhibition, #inotusumab, #venetoclax, and collaborative strides in pediatric & adult oncology for improved outcomes.[video][slides] https://t.co/YP3hFDyFbv @_MDEducation @Ryan_fitzpatric @MDAndersonNews https://t.co/fdaAxQqrmE

  • Mashup Score: 0

    Courtney DiNardo, MD- Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Emerging as a beacon of hope in the realm of acute myeloid leukemia (AML) treatment, a new frontier is being forged through the synergistic power of innovativ…

    Tweet Tweets with this article
    • AML treatment with Courtney DiNardo, MD. Combining #IDH inhibitors #ivosidenib & enasidenib with hypomethylating agents and #venetoclax precision shows promising response rates & MRD reduction. [video][slides]https://t.co/sBgNYKIi6M @_MDEducation @Ryan_fitzpatric @MDAndersonNews https://t.co/n53UUa5XHr